Boropinic acid, a novel inhibitor of Helicobacter pylori stomach colonization

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 210-211

  Touati, Eliette ^a   Michel, Valérie ^a   Correia, Marta ^a,b   Menghini, Luigi ^c   Genovese, Salvatore ^c   Curini, Massimo ^d   Epifano, Francesco ^c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Chemotherapy; H. pylori; Prenyloxycinnamic acid

Indexed keywords

ANTIBIOTIC AGENT; BOROPINIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM DETECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; ERADICATION THERAPY; HELICOBACTER INFECTION; HISTOPATHOLOGY; IN VIVO STUDY; LETTER; MOUSE; NONHUMAN; STOMACH MUCOSA; TOXICITY TESTING;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICE; MICE, INBRED C57BL; MOLECULAR STRUCTURE; STOMACH;

EID: 67249128265     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp136     Document Type: Letter

References (5)

1. Mégraud F. H. pylori antibiotic resistance: Prevalence, importance, and advances in testing. Gut 2004; 53: 1374-84.
2. Epifano F, Menghini L, Pagiotti R et al. In vitro inhibitory activity of boropinic acid against Helicobacter pylori. Bioorg Med Chem Lett 2006; 16: 5523-5.
3. Lee A, O'Rourke J, De Ungria MC et al. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 1997; 112: 1386-97.
4. Touati E, Michel V, Thiberge J et al. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003; 124: 1408-19.
5. O'Rourke JL, Lee A. Animal models of Helicobacter pylori infection and disease. Microbes Infect 2003; 5: 741-8.